RITUXIMAB: COMPARISON CLINICAL AND ANTI-DESTRUCTIVE EFFECTS AND B-CELL COUNT IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Pivanova, A. [1 ]
Lukina, G. [1 ]
Sigidin, Y. [1 ]
Smirnov, A. [1 ]
Glukhova, S. [1 ]
Kuznetsova, A. [1 ]
Kuzikyants, K. [1 ]
Nasonov, E. [1 ]
机构：
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 01期
关键词：
rituximab; anti-destructive effects; B-cells;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PT6B:080
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [1] ANTI-DESTRUCTIVE EFFECT OF RITUXIMAB AND B-CELL COUNT IN RHEUMATOID ARTHRITIS PATIENTS
    Pivanova, Anastasia V.
    Lukina, Galina V.
    Sigidin, Yakov A.
    Smirnov, Aleksandr V.
    Kuzikyants, Kristina Kh
    Kuznetsova, Anna Yu
    Nasonov, Evgeni L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A97 - A97
  • [2] CORRELATION BETWEEN CLINICAL AND ANTI-DESTRUCTIVE EFFECTS OF RITUXIMAB (RTM) AND B-CELLS COUNT IN RHEUMATOID ARTHRITIS (RA) PATIENTS
    Pivanova, A. V.
    Lukina, G.
    Sigidin, Y.
    Smirnov, A. V.
    Kuzikyants, K. Kh.
    Kuznetsova, A. Yu.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1017 - 1017
  • [3] Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
    Breedveld, Ferdinand
    Agarwal, Sunil
    Yin, Ming
    Ren, Song
    Li, Nicole F.
    Shaw, Tim M.
    Davies, Brian E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1119 - 1128
  • [4] Repeated B-cell depletion with rituximab in rheumatoid arthritis
    Edwards, J
    Leandro, M
    [J]. ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 3) : S42 - S42
  • [5] Repeated B-cell depletion with rituximab in rheumatoid arthritis
    J Edwards
    M Leandro
    [J]. Arthritis Res Ther, 5
  • [6] NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
    Lurati, Alfredomaria
    Bertani, Luca
    Marrazza, Mariagrazia
    Re, Katia Angela
    Bompane, Daniela
    Scarpellini, Magda
    [J]. BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 83 - 87
  • [7] THE INFLUENCE OF RITUXIMAB AND TOCILIZUMAB TREATMENT ON B-CELL SUBSETS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Suponitskaya, E.
    Aleksankin, A.
    Avdeeva, A.
    Aleksandrova, E.
    Novikov, A.
    Nasonov, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 498 - 498
  • [8] Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients Association with B-Cell Markers
    Pyrpasopoulou, Athina
    Douma, Stella
    Triantafyllou, Areti
    Simoulidou, Elisavet
    Samara, Magda
    Parapanisiou, Efthymia
    Aslanidis, Spyros
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (01) : 43 - 48
  • [9] Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis
    Dass, Shouvik
    Vital, Edward M.
    Emery, Paul
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (18) : 2559 - 2570
  • [10] Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab
    de la Torre, I.
    Leandro, M. J.
    Edwards, J. C. W.
    Cambridge, G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 554 - 560
12345